[Issues and implementation of postoperative radiotherapy after flap reconstructive surgery in head and neck cancers].
Enjeux et mise en œuvre de radiothérapie postopératoire après chirurgie reconstructrice avec lambeau dans les cancers de la tête et du cou.
Cancer de la tête et du cou
Chirurgie reconstructive
Flap, Radiotherapy
Head and neck cancer
Lambeau
Radiothérapie
Recommandations
Recommendations
Reconstructive surgery
Target volume
Volumes cibles
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
28 Mar 2024
28 Mar 2024
Historique:
received:
05
11
2023
revised:
23
01
2024
accepted:
01
02
2024
medline:
30
3
2024
pubmed:
30
3
2024
entrez:
29
3
2024
Statut:
aheadofprint
Résumé
The management of head and neck cancers is multidisciplinary, often relying on the use of combined treatments to maximize the chances of cure. Combined treatments are however also responsible for cumulative side effects. The aim of reconstructive surgery with a flap is to restore a function lost with the loss of substance from the tumor resection. However, changes in reconstructive surgery have impact of postoperative radiotherapy planning. The optimization of imaging protocols for radiotherapy planning should make it possible to identify postoperative changes and to distinguish flaps from surrounding native tissues to delineate the flaps and document the spontaneous evolution of these flaps or dose-effect relationships in case of radiotherapy. Such changes include atrophy, fibrosis of soft tissue flaps and osteoradionecrosis of bone flaps. Radiotherapy optimization also involves standardization of the definition of target volumes in situations where a flap is present, a situation that is increasingly common in routine care. This evolution of practice, beyond the essential multidisciplinary consultation meetings defining treatment indications, requires a close radio surgical collaboration with respect to technical aspects of the two disciplines. Doing so, anticipation of relapse and toxicity profiles could possibly lead to propose strategies for personalized de-escalation of multimodal treatments through interdisciplinary trials.
Identifiants
pubmed: 38553286
pii: S0007-4551(24)00082-1
doi: 10.1016/j.bulcan.2024.02.002
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.